---
figid: PMC11576080__AH2024-5948170.002
figtitle: Therapeutic interventions that specifically target signaling pathways in
  B-cell lymphoma
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11576080
filename: AH2024-5948170.002.jpg
figlink: /pmc/articles/PMC11576080/figure/F2/
number: F2
caption: The therapeutic interventions that specifically target signaling pathways
  in B-cell lymphoma. The figure illustrates the interconnected network of (a) NF-κB,
  BCR, and (b) PI3K signaling pathways, which provide promising therapeutic targets
  for the treatment of lymphoma. AKT, protein kinase B; Lyn, tyrosine–protein kinase
  Lyn; mTORC1, mammalian target of rapamycin complex 1; NEMO, IKKγ; NF-κB, nuclear
  factor-kappa-B; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol-(4,5)-bisphosphate;
  PIP3, phosphatidylinositol-(3,4,5)-trisphosphate; PTEN, phosphatase and tensin homolog;
  SYK, spleen tyrosine kinase; Ub, ubiquitination
papertitle: 'Advancements in B-Cell Non-Hodgkin''s Lymphoma: From Signaling Pathways
  to Targeted Therapies'
reftext: Abdullah Alfaifi, et al. Adv Hematol. 2024;2024(NA).
year: '2024'
doi: 10.1155/2024/5948170
journal_title: Advances in Hematology
journal_nlm_ta: Adv Hematol
publisher_name: Wiley
keywords: B-cell lymphoma | BCR | JAK/STAT | NF-kB | PI3K/AKT/mTOR | signaling pathways
  | targeted therapy
automl_pathway: 0.9412001
figid_alias: PMC11576080__F2
figtype: Figure
redirect_from: /figures/PMC11576080__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11576080__AH2024-5948170.002.html
  '@type': Dataset
  description: The therapeutic interventions that specifically target signaling pathways
    in B-cell lymphoma. The figure illustrates the interconnected network of (a) NF-κB,
    BCR, and (b) PI3K signaling pathways, which provide promising therapeutic targets
    for the treatment of lymphoma. AKT, protein kinase B; Lyn, tyrosine–protein kinase
    Lyn; mTORC1, mammalian target of rapamycin complex 1; NEMO, IKKγ; NF-κB, nuclear
    factor-kappa-B; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol-(4,5)-bisphosphate;
    PIP3, phosphatidylinositol-(3,4,5)-trisphosphate; PTEN, phosphatase and tensin
    homolog; SYK, spleen tyrosine kinase; Ub, ubiquitination
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - LYN
  - CD79A
  - CD79B
  - SYK
  - BCR
  - RN7SL263P
  - MS4A1
  - KRT20
  - BTK
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - IKBKG
  - NFKBIA
  - NFKB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ptenb
  - lyn
  - si:ch73-206d17.1
  - cd79a
  - cd79b
  - syk
  - bcr
  - btk
  - ikbkg
  - mtor
  - Acalabrutinib
  - Bortezomib
  - lenalidomide
---
